Cyclic AMP signaling as a mediator of vasculogenic mimicry in aggressive human melanoma cells in vitro

Cancer Research

Volumn 69, Issue 3, 2009, Pages 802-809

  Lissitzky, Jean Claude ^a   Parriaux, Danielle ^a   Ristorcelli, Elodie ^a   Vérine, Alain ^a   Lombardo, Dominique ^a   Verrando, Patrick ^a,b  

^a AIX MARSEILLE UNIVERSITY   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIPORTER; BUCLADESINE; CYCLIC AMP; CYCLIC AMP BINDING PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; FORSKOLIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN EPAC; PROTEIN KINASE B; RAP1 PROTEIN; SERINE; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE;

ARTICLE; CANCER CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IN VITRO STUDY; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UVEA MELANOMA;

1-METHYL-3-ISOBUTYLXANTHINE; 1-PHOSPHATIDYLINOSITOL 3-KINASE; ALPHA-MSH; CELL LINE, TUMOR; CYCLIC AMP; FORSKOLIN; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; LIGANDS; MAP KINASE SIGNALING SYSTEM; MELANOMA; MICROVESSELS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOVASCULARIZATION, PATHOLOGIC; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; TELOMERE-BINDING PROTEINS; VASOACTIVE INTESTINAL PEPTIDE;

EID: 59149086719     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-2391     Document Type: Article

References (39)

1. Chin L, Garraway LA, Fisher DE. Malignant melanoma: genetics and therapeutics in the genomic era. Genes Dev 2006;20:2149-82.
2. Markovic SN, Erickson LA, Rao RD, et al. Malignant Melanoma in the 21st Century, Part 2: Staging, Prognosis, and Treatment. Mayo Clin Proc 2007;82:490-513.
3. Bittner M, Meltzer P, Chen Y, et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 2000;406:536-40.
4. Hendrix MJ, Seftor EA, Hess AR, Seftor RE. Molecular plasticity of human melanoma cells. Oncogene 2003;22:3070-5.
5. Hendrix MJ, Seftor EA, Hess AR, Seftor EB. Vasculogenic mimicry and tumor-cell plasticity:lessons from melanoma. Nat Rev Cancer 2003;3:411-21.
6. Zhang S, Zhang D, Sun B. Vasculogenic mimicry: current status and future prospects. Cancer Lett 2007;254:157-64.
7. Maniotis AJ, Folberg R, Hess A, et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 1999;155:739-52.
8. Hess AR, Margaryan NV, Seftor EA, Hendrix MJ. Deciphering the signaling events that promote melanoma tumor cell vasculogenic mimicry and their link to embryonic vasculogenesis: role of the Eph receptors. Dev Dyn 2007;236:3283-96.
9. Postovit LM, Margaryan NV, Seftor EA, Hendrix MJC. Role of Nodal signaling and the microenvironment underlying melanoma plasticity. Pigment Cell Melanoma Res 2008;21:348-57.
10. Kamenetsky M, Middelhaufe S, Bank EM, Levin LR. Molecular details of cAMP generation in mammalian cells: A tale of two Systems. J Mol Biol 2006;362:623-39.
11. Dumaz N, Marais R. Integrating signals between cAMP and the RAS/RAF/MEK/ERK signalling pathways. FEBS J 2005;272:3491-504.
12. Bos JL. Epac proteins: multi-purpose cAMP targets. Trends Biochem Sci 2006;31:680-6.
13. Roscioni SS, Elzinga CR, Schmidt M. Epac: effectors and biological functions. Naunyn Schmiedebergs Arch Pharmacol 2008;377:345-57.
14. Wang Z, Dillon TJ, Pokala V, et al. Rap1-mediated activation of extracellular signal-regulated kinases by cyclic AMP is dependent on the mode of Rap1 activation. Mol Cell Biol 2006;26:2130-45.
15. Somekawa S, Fukuhara S, Nakaoka Y, Fujita H, Saito Y, Mochizuki N. Enhanced functional gap junction neoformation by protein kinase A-dependent and EPAC-dependent signals dowstream of cAMP in cardiac myocytes. Circ Res 2005;97:655-62.
16. Jiang B-H, Liu Z-L. PI3K/PTEN signaling in tumorigenesis and angiogenesis. Biochem Biophys Acta 2008;1784:150-8.
17. Mei FC, Qiao J, Tsygankova OM, Meinkoth JL, Quilliam LA, Cheng X. Differential signaling of cyclic AMP. Opposing effects of exchange protein directly activated by cyclic AMP and cAMP dependent protein kinase on protein kinase B activation. J Biol Chem 2002;277:11497-504.
18. Brennesvik EO, Ktori C, Ruzzin J, Jebensa E, Shepherd PR, Jensena J. Adrenaline potentiates insulin-stimulated PKB activation via cAMP and Epac: implications for cross talk between insulin and adrenaline. Cell Signal 2005;17:1551-9.
19. Misra UK, Pizzo SV. Coordinate regulation of forskolin-induced cellular proliferation in macrophages by protein kinase A/cAMP-response element-binding protein (CREB) and Epac1-1 signaling. Effects of silencing CREB gene expression on Akt activation. J Biol Chem 2005;280:38276-89.
20. Misra UK, Kaczowka SJ, Pizzo S. Interaction between TLC1 and Epac1 in activation of Akt kinases in plasma membranes and nuclei of 8-CPT-2-O-Me-cAMP- stimulated macrophages. Cell Signal 2008;20:130-8.
21. Hess AR, Seftor EA, Gardner LM, et al. Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epthelial cell kinase (Eck/EphA2). Cancer Res 2001;61:3250-5.
22. van Triest M, de Rooij J, Bos JL. Measurement of GTP-bound Ras-like GTPases by activation-specific probes. Methods Enzymol 2001;333:343-8.
23. Busca R, Abbe P, Mantoux F, et al. Ras mediates the cAMP-dependent activation of extracellular signal-regulated kinases (ERKs) in melanocytes. EMBO J 2000;19:2900-10.
24. Casamayor A, Morrice NA, Alessi DR. Phosphorylation of Ser-241 is essential for the activity of 3-phosphoinositide-dependent protein kinase-1: identification of five sites of phosphorylation in vivo. Biochem J 1999;342:287-92.
25. Kavanaugh WM, Turck CW, Klippel A, Williams LT. Tyrosine 508 of the 85-kilodalton subunit of phosphatidylinositol 3-kinase is phosphorylated by the platelet-derived growth factor receptor. Biochemistry 1994;33:11046-50.
26. Lagerström MC, Schiöth HB. Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat Rev Drug Discov 2008;7:339-57.
27. Strosberg AD, Nahmias C. G-protein-coupled receptor signalling through protein networks. Biochem Soc Trans 2007;35:23-7.
28. Hess AR, Postovit L.-M, Margaryan NV, et al. Focal adhesion kinase promotes the aggressive melanoma phenotype. Cancer Res 2005;65:9851-60.
29. Gao L, Feng Y, Bowers R, et al. Ras-associated protein-1 regulates extracellular signal-regulated kinase activation and migration in melanoma cells: two processes important to melanoma tumorigenesis and metastasis. Cancer Res 2006;66:7880-8.
30. Hacker BM, Tomlinson JE, Wayman GA, et al. Cloning, chromosomal mapping, and regulatory properties of the human type 9 adenylyl cyclase (ADCY9). Genomics 1998;50:97-104.
31. Dahle MK, Myrhe AE, Aasen AO, Wang JE. Effects of forskolin on Kupffer cell production of interleukin-10 and tumore necrosis factor a differ from those of endogenous adenylyl cyclase activators: possible role for adenylyl cyclase 9. Infect Immun 2005;73:7290-6.
32. Hess AR, Seftor EA, Seftor EB, Hendrix MJ. Phosphoinositide 3-kinase regulates membrane type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry. Cancer Res 2003;63:4757-62.
33. Cass LA, Summers SA, Prendergast GV, Backer JM, Birnbaum MJ, Meinkoth JL. Protein kinase A-dependent and -independent signaling pathways contribute to cyclic AMP-stimulated proliferation. Mol Cell Biol 1999;19:5882-91.
34. Fukuhara S, Sakurai A, Sano H, et al. Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway. Mol Cell Biol 2005;25:136-46.
35. Bindewald K, Gündüz D, Härtel F, et al. Opposite effect of cAMP signaling in endothelial barriers of different origin. Am J Physiol Cell Physiol 2004;287:C1246-55.
36. Yurugi-Kobayashi T, Itoh H, Schroeder T, et al. Adrenomedullin/cyclic AMP pathway induces Notch activation and differentiation of arterial endothelial cells from vascular progenitors. Arterioscler Thromb Vasc Biol 2006;26:1977-84.
37. Postovit LM, Seftor EA, Seftor RE, Hendrix MJ. Targeting Nodal in malignant melanoma cells. Nat Rev Cancer 2007;7:246-55.
38. Topczewska JM, Postovit LM, Margaryan NV, et al. Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness. Nat Med 2006;12:925-32.
39. Uyttendaele H, Ho J, Rossant J, Kitajewski J. Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium. Proc Natl Acad Sci U S A 2001;98:5643-8.